Médecins pour Thérapie ciblée à l'étranger — Page 3

Spécialisé dans les procédures endoscopiques avancées, le Dr Erdogan apporte son expertise en CPRE (cholangiopancréatographie rétrograde endoscopique), écho-endoscopie (EUS) et traitement des MICI (Maladies Inflammatoires Chroniques de l'Intestin) à l'Hôpital Liv de l'Université İstinye Topkapı.

• Stage clinique (fellowship) en gastro-entérologie à l'Hôpital de la Ville d'Ankara
• A publié plusieurs articles de recherche sur le traitement des maladies inflammatoires de l'intestin
• Expérimenté en myotomie endoscopique par voie orale (POEM) et en dissection sous-muqueuse endoscopique (ESD)
• Contributeur actif à des revues à comité de lecture dans le domaine de la gastro-entérologie

Dr. Yaacov Lawrence is the Chair of Radiation Oncology at Sheba Medical Center. He specializes in precision radiation therapy and neuro-oncology. Dr. Lawrence pioneered celiac plexus radiosurgery for pancreatic cancer pain management. He holds the FASTRO designation, one of the highest honors in his specialty.

• Leads the Gastrointestinal Cancer Program at Sheba Medical Center.
• Performs stereotactic radiosurgery for brain tumors and nervous system cancers.
• Authored over 280 scientific publications on personalized radiation protocols.
• Completed radiation oncology fellowship training at Thomas Jefferson University.

Dr. Beni Boursi is a leading oncologist at Sheba Medical Center. He founded the ECOG-ACRIN Microbiome Working Group. He specializes in treating gastrointestinal cancers using innovative microbial modulation. Dr. Boursi is board certified in internal medicine and medical oncology. He earned his medical degree with highest honors from Tel Aviv University.

• Completed oncology fellowships at the University of Pennsylvania.
• Trained in medical oncology at MD Anderson and Mayo Clinic.
• Developed predictive models for early colorectal and pancreatic cancer diagnosis.
• Published research on microbiome-oncology in the prestigious journal Science.

Dr. Emad Shash is a medical oncologist who has participated in over 70 oncology clinical trials. He serves as the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. Dr. Shash specializes in systemic therapies, including chemotherapy, targeted therapy, and immunotherapy. He holds a Diploma in Hospital Quality Management and Patient Safety from JCI.

• Serves as an ESMO panel voting member and an ASCO committee member.
• Treats breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers.
• Former research physician and medical lead at the EORTC in Brussels.
• Works at Shefaa Al Orman, an ESMO-accredited oncology center treating 6,000 patients annually.

Dr. Lucía González Cortijo is the Head of Medical Oncology at Hospital Universitario Quirónsalud Madrid. She specializes in breast and gynecologic cancers, including ovarian and cervical malignancies. Dr. González Cortijo holds a PhD cum laude and a Master’s in Molecular Oncology. She focuses on precision oncology, immunotherapy, and targeted treatments.

• Principal Investigator in over 20 Phase II–III clinical trials.
• Participated as a sub-investigator in more than 50 international trials.
• Member of the American Society of Clinical Oncology (ASCO) and ESMO.
• Founder of the La Vida en Rosa Foundation for women with cancer.

Dr. Eytan Aharon Ben-Ami leads the Oncology Division at Sheba Medical Center in Israel. He specialized in sarcoma and bone oncology at the Dana-Farber Cancer Institute. Dr. Ben-Ami founded the Sheba Clinical Research Organization to advance cancer studies. He treats rare bone tumors and soft tissue sarcomas with personalized protocols.

• Heads the Early-Phase Clinical Trials Unit for innovative cancer therapies.
• Authored over 40 scientific publications on molecular mechanisms and early detection.
• Leads Phase I trials in targeted therapy and immunotherapy for rare cancers.
• Works at Sheba Medical Center, a top-10 hospital globally per Newsweek.

Dr. Raanan Berger is the Director of the Cancer Center at Sheba Medical Center. He was listed in Forbes Israel’s “Best Doctors” in 2025. Dr. Berger specializes in genitourinary oncology and radiates complex prostate tumors. He completed a postdoctoral fellowship at the Dana-Farber/Harvard Cancer Institute.

• Heads the clinical research unit focusing on molecular oncology.
• Co-authored over 20 peer-reviewed papers on prostate cancer and BRCA mutations.
• Member of the American Society of Clinical Oncology (ASCO).
• Performs systemic therapy and radiotherapy at a Top-10 globally ranked hospital.

Dr. Nir Kleinmann directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is a pioneer in kidney-sparing laser surgery for complex tumors. Forbes and ResultMed named him among Israel’s Best Doctors for 2025 and 2026. Dr. Kleinmann uses a unique dual-laser system to preserve organ function during cancer treatment.

• Completed urological fellowships at Thomas Jefferson University and McMaster University.
• Expert in minimally invasive treatments for UTUC, kidney stones, and prostate cancer.
• Served as a researcher in the OLYMPUS trial for non-surgical chemoablation.
• Fellow of the American Endourology Society with over 60 scientific publications.

Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.

• Chair of the Israel Lung Cancer Group.
• Board-certified in both Medical Oncology and Radiotherapy Oncology.
• Treats patients at Sheba Medical Center, a top-10 globally ranked hospital.
• Uses molecular and genetic profiling to create precise cancer treatment plans.

Uzm. Dr. Erkan Göcen is a Radiation Oncology Specialist at Çerkezköy Private Optimed Hospital (Optimed Health Group). He graduated from İstanbul University, İstanbul Faculty of Medicine (Çapa) in 2003.

Career: He trained and practiced in Radiation Oncology from 2010 to 2012. He worked in public and private health institutions from 2012 to 2016. He served in the private medical sector as a Radiation Oncology Specialist from 2016 to 2023. He has been at Optimed Hospital since 2024.

Clinical interests: cancers of the brain, head and neck, esophagus, stomach, colorectal, pancreas, prostate, bladder, lung, soft tissues (sarcomas), skin, uterus and cervix, and breast. Affiliations: Turkish Society for Radiation Oncology (TROD) and Tekirdağ Medical Chamber. Languages: English and Turkish.

Directeur clinique de l'unité multidisciplinaire du sein aux Kliniken Essen-Mitte – Sherko Kuemmel dirige la recherche et le traitement avancés du cancer du sein.

• 322 publications évaluées par des pairs sur le cancer du sein
• Membre du conseil d'administration de l'AGO – élaboration des directives sur le cancer du sein
• Dirige des essais cliniques internationaux en tant qu'IP mondial
• Membre de la faculté de l'ESMO pour la formation sur le cancer du sein

Médecin-chef du Centre d'oncologie de l'Assuta Medical Center – expert de premier plan en thérapie ciblée.

• Se spécialise dans les traitements d'oncologie de précision
• Vaste expérience des thérapies anticancéreuses personnalisées
• Exerce dans l'un des meilleurs centres anticancéreux d'Israël

Le Professeur Elke Jaeger est une éminente spécialiste des sarcomes et l'une des meilleures oncologues d'Allemagne selon le classement Focus.

• Plus de 35 ans de pratique en oncologie et hématologie
• Chef du service d'Oncologie et d'Hématologie à la Clinique Nordwest
• Spécialisée en thérapie ciblée pour les cas complexes

Le Dr Eckhart Weidemann dirige le secteur d'Hématologie à la Clinique Nordwest – un spécialiste du traitement des troubles sanguins avec plus de 30 ans d'expérience.

• Spécialisé dans les cas de lymphomes non hodgkiniens
• Dirige le service d'hématologie à la Clinique Nordwest
• Professeur avec une vaste expérience universitaire

Le Dr Borde a géré plus de 30 000 TEP-scans et 1 000 patients atteints de cancer de la thyroïde au HCG Manavata Cancer Centre.

• 12 ans d'expérience en médecine nucléaire
• Spécialisé dans les thérapies par iode radioactif et Lu-177 RN
• Maîtrise tous les types de scintigraphies nucléaires et de TEP-TDM
• Recherches publiées dans des revues médicales

35 ans de spécialisation dans les grossesses à haut risque – le Dr Vatsa prend en charge des cas complexes à l'Institut de recherche Fortis Memorial.

• Expert en chirurgies endoscopiques et méthodes diagnostiques
• Spécialisé dans la gestion des grossesses extra-utérines et des fausses couches
• Auteur de plusieurs articles sur l'oncogynécologie
• Membre de l'Association indienne des gynécologues

Le Dr Vinod Raina est spécialisé dans la thérapie ciblée à Fortis Gurgaon, apportant une expertise pointue au traitement du cancer.

• Oncologue médical possédant une vaste expérience en chimiothérapie
• Spécialisé dans les approches de médecine de précision
• Exerce à Fortis Gurgaon, un établissement de santé de premier plan